SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (2192)2/5/2000 6:14:00 PM
From: Hank  Read Replies (1) of 5582
 
"He has a habit of trying to find something negative in everything whether anything negative even exists."

Yeah, it's called the scientific process.

"Hank's criticism of the sample size is without merit because nobody knows what the sample size is."

You just proved my point genius. Since the rhinoviral serotypes of the test subjects wasn't established, nobody knows what the test population size is either.

"Hank never has anything good to say about Gum Tech and doesn't give the company credit where credit is due."

That's not true. I readily admitted that they were pro's at manipulating the media and public opinion. They deserve credit for that.

"Based on Zicam's theoretical mechanism of action, it would be effective on all serotypes of rhinovirus,..."

Total bullshit. Pleconaril attaches to a pocket in the viral coat that is essential for viral uncoating (aka it sheds it's protein coat to release it's genetic content into the cells for replication)during infection. Yet, pleconaril has been proven to be effective against only 50% of all known rhinoviral serotypes even though they all contain this pocket. How do you figure this Mr. Know It All?

Leave the science to scientists and go back to playing with circuits.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext